Zenas BioPharma Management
Management criteria checks 1/4
Zenas BioPharma's CEO is Lonnie Moulder, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is $2.60M, comprised of 4.9% salary and 95.1% bonuses, including company stock and options. directly owns 0.41% of the company’s shares, worth $2.05M. The average tenure of the management team and the board of directors is 0.8 years and 2 years respectively.
Key information
Lonnie Moulder
Chief executive officer
US$2.6m
Total compensation
| CEO salary percentage | 4.9% |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.4% |
| Management average tenure | less than a year |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$129m |
| Jun 30 2024 | n/a | n/a | -US$55m |
| Mar 31 2024 | n/a | n/a | -US$46m |
| Dec 31 2023 | US$3m | US$127k | -US$37m |
Compensation vs Market: Lonnie's total compensation ($USD2.60M) is about average for companies of similar size in the US market ($USD2.14M).
Compensation vs Earnings: Insufficient data to compare Lonnie's compensation with company performance.
CEO
Lonnie Moulder (67 yo)
1.3yrs
Tenure
US$2,601,510
Compensation
Mr. Leon Oliver Moulder, Jr. also known as Lonnie, is Chairman of the Board of Zenas BioPharma, Inc since 2020 and Chief Executive Officer since August 2023. Mr. Moulder, Jr., also known as Lonnie, M.B.A.,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 1.3yrs | US$2.60m | 0.41% $ 2.1m | |
| COO & President | no data | US$1.29m | no data | |
| Chief Business Officer & CFO | less than a year | US$2.57m | no data | |
| Head of Research & Development and Chief Medical Officer. | 1.1yrs | US$1.72m | no data | |
| Chief Legal Officer | less than a year | no data | no data | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data |
0.8yrs
Average Tenure
52yo
Average Age
Experienced Management: ZBIO's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 4.8yrs | US$2.60m | 0.41% $ 2.1m | |
| Independent Director | 2yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 2.8yrs | US$80.10k | 0% $ 0 | |
| Independent Director | 2yrs | no data | 0.14% $ 705.9k | |
| Independent Director | 2yrs | no data | no data | |
| Independent Director | 4.2yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
2.0yrs
Average Tenure
56yo
Average Age
Experienced Board: ZBIO's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.